statement: We generated a carotid collar placement atherosclerosis model in the novel spontaneous HU Uox-KO mouse and demonstrate that urate plays a contributing rather than a causal role in the carotid neointimal lesions, while urate-lowering treatment may bring additional benefits in this HU mouse model. Abstract Hyperuricemia (HU) is a cause of gout. Clinical studies show a link between HU and cardiovascular disease. However, the role of soluble serum urate on atherosclerosis development remains elusive. We aimed to use a new HU mouse model (Uricase/Uox knockout (KO)) to further investigate the relationship between HU and atherosclerosis.
Introduction
Cardiovascular disease (CVD) is the leading cause of death world-wide (Lozano et al., 2012) .
Atherosclerosis is one of the major CVDs characterized by focal intimal thickening and ultimately luminal obstruction induced by fibro-proliferation and an inflammatory process mediated by cytokine production and vascular regulatory mechanisms (Zmuda et al., 2011) .
Neointimal formation happens at the early stage of atherosclerosis which is a complex process initiated by the damage of endothelial cells and exposure of vascular smooth muscle cells to circulating blood elements (Tian et al., 2017) . Hyperuricemia (HU) causes gout and has been implicated in hypertension and atherosclerosis in humans (Odden et al., 2014) .
Epidemiological studies have associated HU with atherosclerotic vascular diseases , and the level of serum urate (SU) can predict cardiovascular outcomes and mortalities in both sexes (Xia et al., 2014) . HU is also a risk factor for hypertension, which is a potent contributor of atherosclerosis (Wu and Chan, 2012) . A meta-analysis of 18 prospective cohort studies, including data from more than 55,000 patients, showed an increased risk of incident hypertension in subjects with HU, and the overall risk increased by 13% per 1 mg/dL increase in SU (Grayson et al., 2011) . More recently, a retrospective cohort study demonstrated that HU plays a significant role in the progression from prehypertension to hypertension with a 35% increasing ratio of hypertension risk in men (Do et al., 2015) . These findings have prompted a growing research interest on the possible benefits of urate-lowering treatment (ULT) in cardiovascular diseases. However, it has not been definitively established whether urate is merely a marker or a causal agent of CVD, or whether ULT affects outcomes.
This study was designed to investigate the relationship between urate and atherosclerosis in a spontaneous HU mouse model with collar-induced neointimal lesions.
Results

Soluble urate does not induce atherosclerotic phenotypes
SU levels in Uox-KO mice were almost 3-fold increased compared to WT counterparts (563.9 μ mol/L ± 16.9 vs. 176.3 μ mol/L ± 6.7, P< 0.001; Table 1 ). Compared with WT controls, BUN and serum creatinine were significantly elevated in Uox-KO mice (Table 1) .
No apparent changes occurred in the fasting glucose level of Uox-KO mice compared with WT mice (Table 1) . Neither did lipid profiles change (TC, HDL-C and LDL-C; Table 1 ).
To evaluate the effects of urate on the cardiovascular system, blood pressure, endothelium-dependent vasodilatation and cardiac function were tested. Systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean blood pressure (MBP) exhibited no difference between Uox-KO mice and WT controls ( Fig. 1A) . Neither did aortae dilation nor cardiovascular function change ( Fig. 1B ; Table 2 ). This does not support a direct role of urate in the control of blood pressure, vasodilation and cardiac function. As shown in Fig 1C and 1D, pathogenic proteins in atherosclerosis were up-regulated in both plasma and carotid lesions -MCP-1, ICAM-1, and VCAM-1 (P< 0.05). However, Uox-KO mice did not present an atherosclerotic phenotype, showing no changes in intimal areas, proliferation (proxied by PCNA-positive cells) and inflammation (proxied by F4/80-positive cells) in Fig. 1E and 1F.
Hyperuricemia accelerates carotid neointimal lesions with collar placement
We next addressed the questions: is the effect of urate evident only once a stress is given, and does ULT affect the atherosclerosis pathogenesis? This perivascular carotid collar model along with western-type diet represents a useful complementary model in which neointimal lesions show up at the early-stage of atherosclerosis. With collar induction HU makes neointimal lesions worse, indicated by the increases in intimal area, more PCNA-and F4/80positive cells in the carotid artery compared with WT collared mice ( Fig. 2C, 2D ).
Administration of allopurinol (100 mg/kg), a xanthine oxidase inhibitor and urate-lowering drug, significantly alleviated the intimal phenotypes including intimal area, PCNA-positive cell counts and F4/80 positive cell counts. Allopurinol also alleviated both SU and renal functions indicated by BUN and creatinine in Uox-KO collared mice compared to WT collared mice (Table 1) . Consistently, allopurinol decreased expression of MCP-1, as well as ICAM-1 and VCAM-1, in both plasma and carotid tissues determined by ELISA and RT-PCR, respectively ( Fig. 2A, 2B ). The down-regulation of MCP-1, ICAM-1, and VCAM-1 in carotid tissue indicated that inflammation was improved by ULT. Echocardiographic analysis of heart rate, diastolic left ventricular internal diameter and ejection fraction exhibited no difference between collared Uox-KO mice and WT controls (data not shown).
Hyperuricemia elevates ROS in carotid artery in vivo
Given ROS plays a putative role in the pathogenesis of atherosclerosis, we tested the ROS intensity by fluorescent dye dihydroethidium staining in the carotid artery of WT and Uox-KO mice. Uox-KO mice had elevated ROS levels compared with WT, with or without collar placement ( Fig 3A, 3B) . ROS intensities were reduced in Uox-KO mice with 100 mg/kg allopurinol treatment for 10 weeks versus WT controls in the presence or absence of collar placement ( Fig 3A, 3B) , implying that urate imposes additional oxidative stress which may accelerate atherosclerosis development.
Soluble urate induces ROS enhancement in vitro
Human umbilical vein endothelial cell (HUVEC) (10 5 /well) viability was measured when co- treated HUVECs was significantly higher than controls and this was lessened by preincubation with probenecid or NAC or both ( Fig. 4E ).
Discussion
The presence of hepatic Uox is the reason that rodents have lower SU compared to humans (Alvarez-Lario and Macarron-Vicente, 2010). When Uox is knocked out, mice develop spontaneous HU similar to the SU level of humans (Lu et al., 2018) . Based on this HU mouse model, we further generated an atherosclerosis model with right carotid artery peri-collar placement and a western-type diet. Using this model we showed that, because Uox-KO mice did not present an atherosclerotic phenotype despite of facts that inflammatory response and ROS indeed were induced in Uox-KO mice. However, HU worsened the development of neointimal lesions through in vivo ROS enhancement.
Epidemiological studies have detected an association between HU and hypertension, while evidence for causation, that includes data from Mendelian randomization studies, is limited and inconclusive (Dehghan et al., 2008; Sluijs et al., 2015; Vitart et al., 2008) .
Hypertension is a risk factor in the pathogenesis of atherosclerosis. Here we describe the cardiovascular characteristics in Uox-KO male mice, which exhibit no signs of heart dysfunction, heart morphology alteration or blood pressure change. This is consistent with data from another HU mouse model with liver Glut9 deficiency (Preitner et al., 2015) . These data therefore do not support a direct causal role of urate on blood pressure in mice.
To our knowledge, this study is the first to assess conducted dilation responses of aortae in the spontaneous HU mouse and showed that urate cannot induce experimentally significant changes of endothelium-dependent vasodilatation. Indeed, when expressed as a function of the dilation, the conducted dilation of aortae in Uox-KO and WT mice was relatively similar. Interestingly, the endothelial relaxation dysfunction reported in aortae from low-density lipoprotein receptor/apolipoprotein E (LDL/ApoE) double knockout mice was in regions with significant lesions, and not in other regions or in aortae from the ApoE single KO mice where lesions were minimal (Beleznai et al., 2011) . Similarly, even in diabetic ApoE-KO mice, endothelial dysfunction was only reported in plaque-prone regions of the aortae, while plaque-resistant segments maintained a normal acetylcholine response (Ding et al., 2005) . These pieces of evidence are consistent with our observation of no vasodilation dysfunction in our Uox-KO mice compared with WT mice.
Our results show that spontaneous HU without any stress does not induce obvious atherosclerosis phenotypes. However, hyperuricemia alone was sufficient to induce oxidative stress and enhance levels of atherosclerosis associated inflammatory cytokines indicating that HU is only a promoting factor rather than an initiator in atherosclerosis. HU may contribute to an activated atherosclerotic pathological process. MCP-1, ICAM-1 and VCAM-1, crucial pathogenic elements in atherosclerosis, are up-regulated in atherosclerotic lesions and influence growth factor production and medial smooth muscle cell migration (Dzau et al., 2002; Hsueh et al., 2016) . HU enhanced MCP-1, ICAM-1 and VCAM-1 as shown in serum level and protein expression, suggesting that these three molecules are also involved in a HUdriven atherosclerosis promoting effect that would exacerbate the pathogenesis of atherosclerosis. The augmented response of MCP-1, ICAM-1 and VCAM-1 to a given concentration of urate would stimulate downstream inflammation and thereby induce atherosclerosis progressing to a greater extent than controls in vitro. Increasing of intimal area due to smooth muscle cell movement and reproduction is an essential component of atherosclerosis, which can be indicated by proliferating cell nuclear antigen (PCNA) . Macrophages accumulate in atherosclerotic plaques, playing crucial roles in atherosclerotic immune responses . Significant increases in intimal areas, PCNA-and F4/80-positive cells in the carotid artery indicates that HU contributes to atherosclerosis, though no plague were found. Despite a few hundred systematic reviews, meta-analyses, and Mendelian randomisation studies exploring 136 unique health outcomes, convincing evidence of a clear causal role of urate in disease pathogenesis only exists for gout and nephrolithiasis (Liu et al., 2015) . Urate is involved in a diverse array of biological functions, while possibly contributing to the pathogenesis of cardiovascular phenotypes, rendering it a pathogenic but not causal role (Alvarez-Lario and Macarron-Vicente, 2010).
HU did associate with an increased risk of cardiovascular death only in participants with gout and existing cardiovascular disease (Muoio and Newgard, 2008) , consistent with our experimental in vivo data.
Reactive oxygen species are another major but non-specific mediator in the formation of atherosclerosis-inducing endothelial dysfunction. It can reduce the bioavailability of nitric oxide, a potential anti-atherosclerotic factor (Montezano and Touyz, 2012). Urate can lead to ROS enhancement which facilitates atherosclerosis by oxidative stress (Forstermann et al., 2017) , which is consistent with our in vivo and in vitro data. Changes in ROS exhibited a similar trend as the change of neointimal lesions in collar-induced Uox-KO mice, which were partially rescued by ULT. This suggests that ROS may also contribute to urate-induced atherosclerosis-promoting effects. The effect of allopurinol (via the active metabolite oxypurinol) that inhibits xanthine oxidase (XO) activity and suppresses urate biosynthesis (Elion, 1966) , also reduces ROS production by inhibiting XO. Other non-XO effects of allopurinol include LDL oxidation prevention, heat shock protein expression inhibition and decreasing early changes in inflammation such as leukocyte activation by reducing adherence, rolling and extravasation (George and Struthers, 2009 ). Given our data shows HU was sufficient to induce both ROS production and atherosclerosis associated inflammatory cytokines, worsened ROS level, inflammatory molecules and neointimal lesions observed in collared Uox-KO mice could be effects due to an "additional action" imposed by HU. Thus, all the neointimal lesions and associated inflammatory factors as well as ROS production were alleviated when ULT was present. In vitro, our study showed the same trend of ROS in vivo. ROS intensities were lowered with probenecid intervention. Combined with probenecid and NAC, the strongest ROS lowering effect was observed (in HUVECs). Thus, the benefits of XO inhibitors such as allopurinol might rely on blocking the production of oxidants rather than on lowering urate (Johnson et al., 2013) . A random, double-blind, crossover study also showed that the mechanism of improvement in endothelial function with high-dose allopurinol lies in its ability to reduce vascular oxidative stress and not in urate reduction (Civelek and Lusis, 2014) . Therefore, although our data exclude a direct causal role of urate per se on atherosclerosis in Uox-KO mice, further studies to address a potential role of XO activity on the cardiovascular function are warranted. Overall, this work reinforces the conclusion that urate accelerates pathogenesis of atherosclerosis and ROS lowering may bring the anti-atherosclerotic effects.
It remains controversial as to whether asymptomatic HU should be treated for the purpose of improving cardiovascular outcomes (Abeles, 2015) . Stamp and Dalbeth (Stamp and Dalbeth, 2017) suggested that asymptomatic HU treatment needs to be cautiously considered, due to the limited data and the potential risks of treatment. Kok et al. (Kok et al., 2014) reported that allopurinol therapy in patients with gout does not yield beneficial cardiovascular outcomes. However, Kuwabara et al. (Kuwabara et al., 2017) promoted the use of ULT for asymptomatic HU in a five-year Japanese cohort study with 13,201 subjects.
ULT was associated to better outcomes in HU patients with cardiovascular diseases accompanied by benefits in endothelial dysfunction and systemic inflammation (Hayashino et al., 2016) . A randomised controlled trial reported that allopurinol reduces central blood pressure and carotid intima-media thickness progression at 1 year in patients with recent ischemic stroke and transient ischemic attack (Higgins et al., 2014) . A mouse study reported that allopurinol represents a potential novel strategy for preventing left ventricular remodelling and dysfunction after myocardial infarction (Engberding et al., 2004) . As well, significant anti-atherosclerotic effects were seen in a HU study in ApoE-KO mice (Wakuda et al., 2014) . Consistently, our results suggest that ULT with allopurinol for hyperuricemic mice may improve neointimal lesions significantly.
Uox-KO mice did not show significant difference in blood pressure, vasodilation or atherosclerotic lesions as compared with controls even urate concentration >560 μ mol/L, comparable to human (Feig et al., 2008) . Even though the Uox-KO mice developed chronic renal dysfunction with a trend for increased plasma BUN, creatinine and chronic renal inflammation and fibrosis (Lu et al., 2018) , there was no correlation between renal or metabolic dysfunction and atherosclerosis development in this mouse model.
It is important to note that there was only approximately 40% of survivors in the Uox-KO birth cohort (Lu et al., 2018) . Thus, the survived Uox-KO mice with constant high UA levels may represent biased subjects and they normally develop significant metabolic and renal dysfunction, which actually mimics the human cases of gout and hyperuricemia with severe complications. A transient increase in uricosuria during the first two weeks of life in Uox-deficient mice might be responsible for the relative low survival rate (Flannick and Florez, 2016 ). The current model is useful to study the asymptomatic HU from a metabolic perspective though it is not fully understood the reasons of poor survival rate.
There is phenotypic heterogeneity existed between sexes in the Uox-KO model. Female
Uox-KO mice have elevation in blood pressure compared with WT counterparts, while males do not (Lu et al., 2018) . In addition, the association between SU and hypertension might vary according to age and sex, being more significant in younger and female subjects (Batzoglou and Schwartz, 2014) . To avoid confounding factor due to gender or sex hormone difference, we only chose male mice in the current study. Further investigation in females would help to delineate a full picture of the effect of HU on cardiovascular diseases.
In conclusion, this is the first evidence to demonstrate that urate plays a contributing rather than a causal role in the carotid neointimal lesions, while ULT may bring additional benefits in this spontaneous HU mouse model. Clinical and mechanism studies are warranted to investigate the ULT's anti-atherosclerotic benefits in atherosclerosis patients with HU.
Materials and Methods
Mouse model
The spontaneous HU mice were developed by knock-out of the hepatically-expressed Uricase (Uox) gene (Lu et al., 2018) . Controls were their wild type (WT) littermates on the C57BL/6J background. As previously described (Baetta et al., 2007) , we generated perivascular carotid collar placement mouse models with non-occlusive silastic collars (length, 5 mm; internal diameter, 0.3 mm; external diameter, 0.6 mm) in 10-week-old males.
Four weeks before surgery, the animals received high-fat, high-cholesterol (HF/HC) westerntype diets (21% (wt/wt) fat and 0.15% cholesterol). Mice were anesthetized by ketamine/xylazine and kept on continuous anesthesia during the surgery. Subsequently, a midline neck incision was made to surgically expose the right carotid artery, and the collar was positioned around the right carotid artery and held in place with a nylon sleeve. Both carotid sheaths were openned, and the common carotid arteries were dissected free from the surrounding connective tissue. The carotid arteries were then returned to their original position and the wound was sutured. After a 6-week collar placement with western-type diet, all mice were sacrificed for subsequent measurements. To evaluate the urate-lowering effect, mice were gavaged with allopurinol at a dose of 100 mg/kg from 6 weeks to 16 weeks of age with collar induction at 10-week-old.
Mice were housed under specific pathogen free (SPF) conditions at 22°C under a 12-h light/dark photoperiod with ad libitum access to rodent diet and sterile water (Zhang et al., 2010) . The Animal Research Ethics Committee of the Affiliated Hospital of Qingdao University approved this study.
Blood biochemistry
Mice were fasted overnight before blood collection from the outer canthus. All biochemical indicators including SU, blood urea nitrogen (BUN), serum creatinine, fasting glucose, lipid profiles (total cholesterol (TC), triglyceride (TG), high-and low-density lipoprotein cholesterol (HDL-C, LDL-C) were measured by an automatic biochemical analyser (Toshiba).
ELISA
Plasma monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) levels were quantified using an enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems).
Quantitative real-time RT-PCR
Total RNA was isolated from the carotid artery or cell line using trizol reagent (Roche Pharmaceuticals) and then reverse transcribed using a Fast Quant RT kit (Takara-Bio), was used to calculate relative mRNA expression, with each measurement performed in triplicate. Primer sequences are shown in Supplementary Table 1 .
Western blot
Protein was extracted from the carotid artery. 50 μ g protein lysates were loaded and transferred to nitrocellulose membranes. Blots were incubated with the primary antibodies
(1:2000, Abcam) against MCP-1 (Catalog no. ab25124), ICAM-1 (Catalog no. ab119871), VCAM-1 (Catalog no. ab134047) and GAPDH (Catalog no. ab8245) at 4°C overnight. After incubation with horseradish peroxidase-conjugated goat anti-rabbit secondary antibodies, visualization was performed with an enhanced chemiluminescence kit (Thermo Scientific).
Each measurement was performed in triplicate.
Echocardiographic analysis
Echocardiography was performed after anesthesia with isoflurane using a Vevo 2100 ultrasound system equipped with a MS400 probe (VisualSonics) for in vivo transthoracic 
Blood pressure
Systolic (SBP) and diastolic (DBP) blood pressure was measured by the CODA programmable noninvasive tail-cuff sphygmomanometer (Kent Scientific). Mice underwent an acclimation period of 7 consecutive days to the sphygmomanometer before experiments.
Mean blood pressure (MBP) was calculated as (DBP + 1/3 [SBP -DBP]).
Assessment of endothelium-dependent vasodilatation
Vasorelaxation of isolated aortic ring segments were determined in oxygenated Kreb's solution. Aortic rings were precontracted with 0.1 μ mol/L noradrenaline after an equilibration period of 60 min. Dilation at each acetylcholine (0.001, 0.01, 0.1, 1.0, 10 μ mol/L) concentration was measured and expressed as the percentage in response to noradrenaline.
Pathology analysis and immunohistochemistry
Carotid arteries were removed and fixed in formalin followed by paraffin embedding of 5 μ m serial sections. Tissue serial sections were incubated with anti-mouse proliferating cell nuclear antigen (PCNA, 1:50, Santa Cruz, Catalog no. sc25280) and anti-mouse F4/80 (macrophage-specific marker, 1:50, Santa Cruz, Catalog no. sc52664) rabbit polyclonal antibodies. Images were captured by Nikon Eclipse TE2000-S microscope (Nikon) and
analysed by Image-Pro Plus software (version 6.0).
Reactive oxygen species (ROS) measurement
Samples were incubated with 2 μ mol/L dihydroethidium (DHE) fluorescence probe (Thermo Scientific) for 30 min at 37°C in the dark to measure ROS levels. Fluorescence was determined using a Nikon 90i (Nikon) with excitation wavelength at 480 nm and emission wavelength at 610 nm.
Soluble urate
As previously described (Eisenbacher et al., 2014) , soluble urate was prepared by dissolving uric acid (UA, Sigma) in warmed media containing 1 M NaOH. The solution was tested to be free of mycoplasma, endotoxin and filtered before use. Crystals were not detectable under polarizing microscopy, nor did they develop during cell incubation.
Cell Culture
Human 
Statistical analysis
All statistical analyses were performed using GraphPad Prism software (version 7). Data were presented as the mean ± SEM. Differences between groups were analyzed by Student's t test or one-way analysis of variance followed by Newman-Keuls multiple comparison test as appropriate. P< 0.05 was considered to be statistically significant. 
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